Literature DB >> 22841579

Experimental models of dermal fibrosis and systemic sclerosis.

Jérôme Avouac1, Muriel Elhai, Yannick Allanore.   

Abstract

Vasculopathy, immunological abnormalities, and fibrosis are the key features in the pathogenesis of systemic sclerosis (SSc). Expression of each of the three pathologic features varies among SSc patients leading to disease heterogeneity and variable organ manifestations. Although the etiology of SSc has not yet been fully elucidated, a growing body of evidence suggests that extracellular matrix overproduction by activated fibroblasts results from a complex interplay between endothelial cells, immune cells and fibroblasts through cell-cell and cell-matrix interactions and communications. Relevant animal models are essential tools to in-depth investigate pathogenesis of SSc. Several murine and avian models are available; however, some models display inflammation followed by fibrosis, whether some others primarily mimic autonomous fibroblast activation. In addition, typical microvascular changes of SSc are only observed in few models. Therefore, none of these animal models encompasses all features of the human disease and a critical selection is mandatory for successful in vivo studies. Hence, we will provide an overview of the most important experimental models of dermal fibrosis and SSc and discuss their respective contribution to the better understanding of SSc pathogenesis.
Copyright © 2012 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22841579     DOI: 10.1016/j.jbspin.2012.06.005

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  5 in total

1.  RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.

Authors:  Chenming Sun; Shi-You Chen
Journal:  J Immunol       Date:  2018-03-05       Impact factor: 5.422

Review 2.  Molecular and cellular basis of scleroderma.

Authors:  Beate Eckes; Pia Moinzadeh; Gerhard Sengle; Nico Hunzelmann; Thomas Krieg
Journal:  J Mol Med (Berl)       Date:  2014-07-18       Impact factor: 4.599

3.  Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.

Authors:  Nadira Ruzehaji; Jerome Avouac; Muriel Elhai; Maxime Frechet; Camelia Frantz; Barbara Ruiz; Joerg H Distler; Yannick Allanore
Journal:  Arthritis Res Ther       Date:  2015-05-30       Impact factor: 5.156

4.  Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice.

Authors:  Yinghua Song; Lubing Zhu; Ming Li
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

5.  Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis.

Authors:  Jérôme Avouac; Maeva Vallucci; Vanessa Smith; Patricia Senet; Barbara Ruiz; Alberto Sulli; Carmen Pizzorni; Camille Frances; Gilles Chiocchia; Maurizio Cutolo; Yannick Allanore
Journal:  Arthritis Res Ther       Date:  2013-04-19       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.